Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012

Journal of Perinatology

Volumn 35, Issue 8, 2015, Pages 650-655

  Patrick, S W ^a,b,c   Davis, M M ^d,e   Lehmann, C U ^a,b,c   Cooper, W O ^a,c  

^a VANDERBILT UNIVERSITY   (United States)

^b MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG MISUSE; FEMALE; GEOGRAPHIC DISTRIBUTION; HOSPITAL CHARGE; HOSPITAL DISCHARGE; HUMAN; ICD-9-CM; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAID; PRIMARY PREVENTION; PUBLIC HEALTH PROBLEM; RETROSPECTIVE STUDY; UNITED STATES; WITHDRAWAL SYNDROME; ECONOMICS; HEALTH SURVEY; NEONATAL ABSTINENCE SYNDROME; NEWBORN; TRENDS;

ANALGESICS, OPIOID; FEMALE; HOSPITAL CHARGES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MEDICAID; NEONATAL ABSTINENCE SYNDROME; POPULATION SURVEILLANCE; UNITED STATES;

EID: 84938292107     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2015.36     Document Type: Article

References (36)

1. Hudak ML, Tan RC. Neonatal drug withdrawal. Pediatrics 2012; 129(2): e540-e560.
2. Kellogg A, Rose CH, Harms RH, Watson WJ. Current trends in narcotic use in pregnancy and neonatal outcomes. Am J Obstet Gynecol 2011; 204(3): 259e1-4.
3. Finnegan LP, Kron RE, Connaughton JF, Emich JP. Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int J Clin Pharmacol Biopharm 1975; 12(1-2): 19-32.
4. Patrick SW, Kaplan HC, Passarella M, Davis MM, Lorch SA. Variation in treatment of neonatal abstinence syndrome in US children's hospitals, 2004-2011. J Perinatol 2014; 34(11): 867-872.
5. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012; 307(18): 1934-1940.
6. Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR Morb Mortal Wkly Rep 2011; 60(43): 1487-1492.
7. Epstein RA, Bobo WV, Martin PR, Morrow JA, Wang W, Chandrasekhar R et al. Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol 2013; 23(8): 498-503.
8. Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among medicaid-enrolled women. Obstet Gynecol 2014; 123(5): 997-1002.
9. Paulozzi LJ, Mack KA, Hockenberry JM. Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines-United States, 2012. MMWR Morb Mortal Wkly Rep 2014; 63(26): 563-568.
10. Centers for Disease Control and Prevention. Prescription Drug Overdose in the United States: Fact Sheet Atlanta, GA: Centers for Disease Control and Prevention; 2014. Available at http://www.cdc.gov/homeandrecreationalsafety/overdose/facts.html.
11. HCUP Kids' Inpatient Database. Healthcare Cost and Utilization Project (HCUP) Rockville, MD: Agency for Healthcare Research and Quality; 2000, 2003, 2006, 2009, 2012. Available at http://www.hcup-us.ahrq.gov/kidoverview.jsp.
12. HCUP Nationwide Inpatient Sample. Healthcare Cost and Utilization Project (HCUP) Rockville, MD: Agency for Healthcare Research and Quality; 2009-2011. Available at http://www.hcup-us.ahrq.gov/nisoverview.jsp.
13. Patrick SW, Davis MM, Sedman AB, Meddings JA, Hieber S, Lee GM et al. Accuracy of hospital administrative data in reporting central line-associated bloodstream infections in newborns. Pediatrics 2013; 131(Suppl 1): S75-S80.
14. Auger KA, Patrick SW, Davis MM. Infant hospitalizations for pertussis before and after Tdap recommendations for adolescents. Pediatrics 2013; 132(5): e1149-e1155.
15. Afana M, Brinjikji W, Cloft H, Salka S. Hospitalization costs for acute myocardial infarction patients treated with percutaneous coronary intervention in the United States are substantially higher than medicare payments. Clin Cardiol 2014; 38(1): 13-19.
16. Kozhimannil KB, Arcaya MC, Subramanian SV. Maternal clinical diagnoses and hospital variation in the risk of cesarean delivery: analyses of a National US hospital discharge database. PLoS Med 2014; 11(10): e1001745.
17. International Classification of Diseases. Clinical Modification. American Medical Association, 9th Revision, Chicago, IL, USA, 2012; p 360.
18. US Bureau of Labor Statistics. Consumer Price Index 2014 [cited 15 July 2014]. Available at http://www.bls.gov/cpi/.
19. Pisati M. Simple thematic mapping. Stata J 2004; 4: 361-378.
20. National Oceanic and Atmospheric Administration. US States and Territories Silver Spring, MD2014. Available at http://www.nws.noaa.gov/geodata/catalog/national/html/us
21. Eapen V, Dadds M, Barnett B, Kohlhoff J, Khan F, Radom N et al. Separation anxiety, attachment and inter-personal representations: disentangling the role of oxytocin in the perinatal period. PLoS One 2014; 9(9): e107745.
22. Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol 2006; 26(1): 15-17.
23. Hall ES, Wexelblatt SL, Crowley M, Grow JL, Jasin LR, Klebanoff MA et al. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics 2014; 134(2): e527-e534.
24. Agthe AG, Kim GR, Mathias KB, Hendrix CW, Chavez-Valdez R, Jansson L et al. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics 2009; 123(5): e849-e856.
25. Jansson LM. ABM clinical protocol #21: guidelines for breastfeeding and the drugdependent woman. Breastfeed Med 2009; 4(4): 225-228.
26. Wachman EM, Hayes MJ, Brown MS, Paul J, Harvey-Wilkes K, Terrin N et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA 2013; 309(17): 1821-1827.
27. Jansson LM, Velez M, Harrow C. Methadone maintenance and lactation: a review of the literature and current management guidelines. J Hum Lact 2004; 20(1): 62-71.
28. Abrahams RR, Kelly SA, Payne S, Thiessen PN, Mackintosh J, Janssen PA. Roomingin compared with standard care for newborns of mothers using methadone or heroin. Can Fam Physician 2007; 53(10): 1722-1730.
29. Hunseler C, Bruckle M, Roth B, Kribs A. Neonatal opiate withdrawal and roomingin: a retrospective analysis of a single center experience. Klin Padiatr 2013; 225(5): 247-251.
30. Saiki T, Lee S, Hannam S, Greenough A. Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. Eur J Pediatr 2010; 169(1): 95-98.
31. ACOG Committee on Health Care for Underserved Women, American Society of Addiction Medicine. ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy. Obstetrics and Gynecology (New York 1953) 2012; 119(5): 1070-1076.
32. Fullerton CA, Kim M, Thomas CP, Lyman DR, Montejano LB, Dougherty RH et al. Medication-assisted treatment with methadone: assessing the evidence. Psychiatr Serv 2014; 65(2): 146-157.
33. Tenn Care. Neonatal Abstinence Syndrome among Tenncare enrollees Provisional 2012 data Nashville, TN2013 [cited 27 October 2014]. Available at http://www.tn. gov/tenncare/forms/TennCareNASData2012.pdf.
34. PDMP Assist. PDMP program status 2014 [cited 18 June 2014]. Available at http://www.pdmpassist.org/pdf/PDMPProgramStatus2014.pdf.
35. Peirce GL, Smith MJ, Abate MA, Halverson J. Doctor and pharmacy shopping for controlled substances. Med Care 2012; 50(6): 494-500.
36. Burns L, Mattick RP. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug Alcohol Rev 2007; 26(5): 487-492.